Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients

NCT04887545 is registered in ClinicalTrials.gov with Universidade Nova de Lisboa as lead sponsor.

NCT NCT04887545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04887545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
Lead sponsor
Universidade Nova de Lisboa
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2018
Completion date
December 1, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, malignancy